BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26399488)

  • 21. [Relationship of dose-volume histogram parameters and computed tomography grading of radiation-induced lung injury in patients with non-small cell lung cancer treated by three-dimensional conformal radiotherapy].
    Xing J; Li JB; Yu JM; Lu J; Xu M; Fan TY; Shao Q; Guo SF
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):676-81. PubMed ID: 19173909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Near-maximum rib dose is the most relevant risk factor for ipsilateral spontaneous rib fracture: a dosimetric analysis of breast cancer patients after radiotherapy.
    Kim D; Kim K; Kim JS; Kang S; Park JM; Shin KH
    Strahlenther Onkol; 2023 Jan; 199(1):38-47. PubMed ID: 35794206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of radiation pneumonitis following high-dose thoracic radiation therapy by 3 Gy/fraction for non-small cell lung cancer: analysis of clinical and dosimetric factors.
    Oh D; Ahn YC; Park HC; Lim DH; Han Y
    Jpn J Clin Oncol; 2009 Mar; 39(3):151-7. PubMed ID: 19193653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation.
    Binkley MS; Hiniker SM; Chaudhuri A; Maxim PG; Diehn M; Loo BW; Shultz DB
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):808-15. PubMed ID: 26831903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-volume histogram analysis of brainstem necrosis in head and neck tumors treated using carbon-ion radiotherapy.
    Shirai K; Fukata K; Adachi A; Saitoh JI; Musha A; Abe T; Kanai T; Kobayashi D; Shigeta Y; Yokoo S; Chikamatsu K; Ohno T; Nakano T
    Radiother Oncol; 2017 Oct; 125(1):36-40. PubMed ID: 28867558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of automatic segmentation of ribs for NTCP modeling.
    Stam B; Peulen H; Rossi MM; Belderbos JS; Sonke JJ
    Radiother Oncol; 2016 Mar; 118(3):528-34. PubMed ID: 26743835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy.
    Ricardi U; Filippi AR; Guarneri A; Giglioli FR; Mantovani C; Fiandra C; Anglesio S; Ragona R
    Acta Oncol; 2009; 48(4):571-7. PubMed ID: 19031164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and dosimetric risk factors of acute esophagitis in patients treated with 3-dimensional conformal radiotherapy for non-small-cell lung cancer.
    Zhang ZC; Xu J; Li BS; Zhou T; Lu J; Wang ZT; Li HS; Sun HF; Zhu J; Yu JM
    Am J Clin Oncol; 2010 Jun; 33(3):271-5. PubMed ID: 19823071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dosimetric parameters predictive of nasolacrimal duct obstruction after carbon-ion radiotherapy for head and neck carcinoma.
    Kubo N; Kubota Y; Kawamura H; Oike T; Sakai M; Kumazawa T; Miyasaka Y; Okazaki S; Kobayashi D; Sato H; Mizukami T; Musha A; Shirai K; Saitoh JI; Yokoo S; Chikamatsu K; Ohno T; Nakano T
    Radiother Oncol; 2019 Dec; 141():72-77. PubMed ID: 31439449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temporal lobe reactions after carbon ion radiation therapy: comparison of relative biological effectiveness-weighted tolerance doses predicted by local effect models I and IV.
    Gillmann C; Jäkel O; Schlampp I; Karger CP
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1136-41. PubMed ID: 24661667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and risk factors for chest wall toxicity after risk-adapted stereotactic radiotherapy for early-stage lung cancer.
    Bongers EM; Haasbeek CJ; Lagerwaard FJ; Slotman BJ; Senan S
    J Thorac Oncol; 2011 Dec; 6(12):2052-7. PubMed ID: 22052227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Phase I Study of Hypofractionated Carbon-ion Radiotherapy for Stage III Non-small Cell Lung Cancer.
    Saitoh JI; Shirai K; Abe T; Kubo N; Ebara T; Ohno T; Minato K; Saito R; Yamada M; Nakano T;
    Anticancer Res; 2018 Feb; 38(2):885-891. PubMed ID: 29374716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective nonrandomized phase I/II study of carbon ion radiotherapy in a favorable subset of locally advanced non-small cell lung cancer (NSCLC).
    Takahashi W; Nakajima M; Yamamoto N; Yamashita H; Nakagawa K; Miyamoto T; Tsuji H; Kamada T; Fujisawa T
    Cancer; 2015 Apr; 121(8):1321-7. PubMed ID: 25641119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A cortical thickness and radiation dose mapping approach identifies early thinning of ribs after stereotactic body radiation therapy.
    Okoukoni C; Lynch SK; McTyre ER; Randolph DM; Weaver AA; Blackstock AW; Lally BE; Munley MT; Willey JS
    Radiother Oncol; 2016 Jun; 119(3):449-53. PubMed ID: 27072937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer.
    Pierce SM; Recht A; Lingos TI; Abner A; Vicini F; Silver B; Herzog A; Harris JR
    Int J Radiat Oncol Biol Phys; 1992; 23(5):915-23. PubMed ID: 1639653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of acute radiation-induced esophagitis with glutamine in non-small cell lung cancer patients treated with radiotherapy: evaluation of clinical and dosimetric parameters.
    Topkan E; Yavuz MN; Onal C; Yavuz AA
    Lung Cancer; 2009 Mar; 63(3):393-9. PubMed ID: 18691789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chest wall dose in MammoSite breast brachytherapy: radiobiologic estimations of late complication risk based on dose-volume considerations.
    Dragun AE; Aguero EG; Harmon JF; Harper JL; Jenrette JM
    Brachytherapy; 2005; 4(4):259-63. PubMed ID: 16344255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low incidence of chest wall pain with a risk-adapted lung stereotactic body radiation therapy approach using three or five fractions based on chest wall dosimetry.
    Coroller TP; Mak RH; Lewis JH; Baldini EH; Chen AB; Colson YL; Hacker FL; Hermann G; Kozono D; Mannarino E; Molodowitch C; Wee JO; Sher DJ; Killoran JH
    PLoS One; 2014; 9(4):e94859. PubMed ID: 24728448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative evaluation of correlation of dose and FDG-PET uptake value with clinical chest wall complications in patients with lung cancer treated with stereotactic body radiation therapy.
    Algan O; Confer M; Algan S; Matthiesen C; Herman T; Ahmad S; Ali I
    J Xray Sci Technol; 2015; 23(6):727-36. PubMed ID: 26756408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dosimetric correlations of acute esophagitis in lung cancer patients treated with radiotherapy.
    Takeda K; Nemoto K; Saito H; Ogawa Y; Takai Y; Yamada S
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):626-9. PubMed ID: 15936536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.